Jianjing Gao is co-founder and President of Muir PT, where she spearheads the disruptive innovation business model of Muir to redefine HealthCare 4.0.
She is a graduate of Greenwich University, and is a student of Professor Clayton Christiansen’s Harvard Business School’s Disruptive Innovation program.
Together with Kevin Paul, JianJing has assembled a team of leaders, innovators and healthcare partners to deliver Affordable, Accessible and Available Proton Therapy to patients.